Clinical Trials
1
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Safety, Tolerability, and Treatment Effect of Belnacasan in Patients With COVID-19
- First Posted Date
- 2021-12-20
- Last Posted Date
- 2022-11-23
- Lead Sponsor
- MedStar Health
- Target Recruit Count
- 43
- Registration Number
- NCT05164120
- Locations
- 🇺🇸
MedStar Washington Hospital Center, Washington, District of Columbia, United States
🇺🇸MedStar Franklin Square, Baltimore, Maryland, United States
News
MedHub-AI Receives PMDA Approval for AI-Powered Coronary Assessment Technology in Japan
MedHub-AI's AutocathFFR® becomes the first fully automated AI-powered software to receive PMDA approval in Japan for calculating Fractional Flow Reserve values directly from X-ray angiograms without invasive procedures.
Blood Test Detects Early Liver Transplant Rejection Using Cell-Free DNA Analysis
Georgetown University and MedStar Health researchers developed a blood test that uses circulating cell-free DNA fragments to detect early signs of liver transplant rejection and complications.
Pharmacists Emerge as Critical Partners in Multiple Sclerosis B-Cell Therapy Management
Pharmacists are taking on expanded roles in shared decision-making for multiple sclerosis treatment, helping patients navigate complex B-cell therapies and improving treatment adherence.